Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities—AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia January 2020 20(1):24-30 - Subject
- Language
- ISSN
- 2152-2650